Search

Julie Ha

Examiner (ID: 10419, Phone: (571)272-5982 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
1467
Issued Applications
922
Pending Applications
143
Abandoned Applications
441

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18293897 [patent_doc_number] => 20230103583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING INTRAOCULAR PRESSURE [patent_app_type] => utility [patent_app_number] => 17/802676 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802676 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/802676
METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING INTRAOCULAR PRESSURE Feb 25, 2021 Abandoned
Array ( [id] => 18496168 [patent_doc_number] => 20230218721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => INCRETIN ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/916169 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916169 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916169
INCRETIN ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF Feb 25, 2021 Pending
Array ( [id] => 17095317 [patent_doc_number] => 20210283108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => METHOD FOR TREATING NEURODEGENERATIVE DISEASES [patent_app_type] => utility [patent_app_number] => 17/186435 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186435 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/186435
METHOD FOR TREATING NEURODEGENERATIVE DISEASES Feb 25, 2021 Abandoned
Array ( [id] => 18171765 [patent_doc_number] => 11571458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-07 [patent_title] => Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health [patent_app_type] => utility [patent_app_number] => 17/187535 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 24957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187535 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/187535
Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health Feb 25, 2021 Issued
Array ( [id] => 16961604 [patent_doc_number] => 20210213103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => METHODS OF TREATING DRY EYE SYNDROME [patent_app_type] => utility [patent_app_number] => 17/185583 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14803 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185583 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/185583
METHODS OF TREATING DRY EYE SYNDROME Feb 24, 2021 Abandoned
Array ( [id] => 18251782 [patent_doc_number] => 20230078821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => Apoaequorin and Curcumin Containing Compositions and Methods [patent_app_type] => utility [patent_app_number] => 17/801619 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801619 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801619
Apoaequorin and Curcumin Containing Compositions and Methods Feb 22, 2021 Pending
Array ( [id] => 20212572 [patent_doc_number] => 12409206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Use of cyclosporine analogues for treating fibrosis [patent_app_type] => utility [patent_app_number] => 17/179406 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 19254 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179406 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179406
Use of cyclosporine analogues for treating fibrosis Feb 18, 2021 Issued
Array ( [id] => 18252356 [patent_doc_number] => 20230079395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/795836 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795836 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/795836
OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF Feb 11, 2021 Pending
Array ( [id] => 18228966 [patent_doc_number] => 20230067960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => TRIPLE AGONIST FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR, GLUCAGON RECEPTOR, AND GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR [patent_app_type] => utility [patent_app_number] => 17/788738 [patent_app_country] => US [patent_app_date] => 2021-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6387 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788738 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/788738
TRIPLE AGONIST FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR, GLUCAGON RECEPTOR, AND GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR Feb 6, 2021 Pending
Array ( [id] => 16870072 [patent_doc_number] => 20210163539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => Wet Adhesive Peptides [patent_app_type] => utility [patent_app_number] => 17/163733 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163733 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/163733
Wet adhesive peptides Jan 31, 2021 Issued
Array ( [id] => 18932341 [patent_doc_number] => 11884748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases [patent_app_type] => utility [patent_app_number] => 17/161370 [patent_app_country] => US [patent_app_date] => 2021-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 62127 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161370 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/161370
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Jan 27, 2021 Issued
Array ( [id] => 18293989 [patent_doc_number] => 20230103675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => ALLERGEN PROTECTION FOR THE SKIN [patent_app_type] => utility [patent_app_number] => 17/759634 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759634 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/759634
ALLERGEN PROTECTION FOR THE SKIN Jan 25, 2021 Pending
Array ( [id] => 18299471 [patent_doc_number] => 20230109157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN [patent_app_type] => utility [patent_app_number] => 17/759635 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759635 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/759635
TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN Jan 25, 2021 Pending
Array ( [id] => 18227055 [patent_doc_number] => 20230066049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETES [patent_app_type] => utility [patent_app_number] => 17/759712 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759712 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/759712
PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETES Jan 25, 2021 Pending
Array ( [id] => 18266763 [patent_doc_number] => 20230088005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => THERAPEUTIC USES OF DULAGLUTIDE [patent_app_type] => utility [patent_app_number] => 17/795797 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795797 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/795797
THERAPEUTIC USES OF DULAGLUTIDE Jan 21, 2021 Pending
Array ( [id] => 18529955 [patent_doc_number] => 20230235022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/793545 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793545 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/793545
NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOF Jan 18, 2021 Pending
Array ( [id] => 18347207 [patent_doc_number] => 20230135317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKIN [patent_app_type] => utility [patent_app_number] => 17/793854 [patent_app_country] => US [patent_app_date] => 2021-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/793854
COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKIN Jan 17, 2021 Pending
Array ( [id] => 18210331 [patent_doc_number] => 20230056593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => ARGININE ASPARTATE-CONTAINING COMPOSITION FOR SUPPRESSING OLD PERSON SMELL [patent_app_type] => utility [patent_app_number] => 17/792844 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792844 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/792844
ARGININE ASPARTATE-CONTAINING COMPOSITION FOR SUPPRESSING OLD PERSON SMELL Jan 12, 2021 Pending
Array ( [id] => 18027800 [patent_doc_number] => 11510961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof [patent_app_type] => utility [patent_app_number] => 17/129837 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 3488 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129837 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129837
Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof Dec 20, 2020 Issued
Array ( [id] => 18412103 [patent_doc_number] => 11666630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Polypeptides for managing viral infections [patent_app_type] => utility [patent_app_number] => 17/127161 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 41 [patent_no_of_words] => 23822 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127161 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127161
Polypeptides for managing viral infections Dec 17, 2020 Issued
Menu